GUCY2C and central nervous system cancer: Cheng et al. [47] described the blocking activity of CTX on a single Cl-specific peptide blocker, a glioma-specific chloride channel (GCC) while Turner and Sontheimer [131] reported high-grade tumors expressing GCC more than low-grade tumors, while healthy tissues or tumors of non-glial origin poorly expressed these channels.